FHAM
BIIB icon

Folger Hill Asset Management’s Biogen BIIB Stock Holding History

Folger Hill Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-30,100
Closed -$8.17M – 187
2017
Q2 		$8.17M Buy
+30,100
New +$7.96M 0.73% 52

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Folger Hill Asset Management's BIIB Position: Q3 2017 in Review

Folger Hill Asset Management sold out of Biogen (BIIB) in Q3 2017, closing a stake of 30,100 shares — an estimated $8.17M sold.

Folger Hill Asset Management first reported a position in BIIB in Q2 2017 and held it in 1 quarter. The position peaked at $8.17M in Q2 2017. 1,015 funds tracked by Wall St. Rank hold BIIB as of Q3 2017.

  • Folger Hill Asset Management reported no remaining Biogen position as of Q3 2017 after selling out during the quarter.
  • Folger Hill Asset Management sold 30,100 Biogen shares in Q3 2017, an estimated $8.17M.
  • Folger Hill Asset Management first reported a position in Biogen in Q2 2017 and held it in 1 quarter.
  • Folger Hill Asset Management's Biogen position peaked at $8.17M in Q2 2017.
  • 1,015 funds tracked by Wall St. Rank held Biogen as of Q3 2017.

Based on Folger Hill Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.